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Glycoprotein-binding site of dystrophin is confined to the cysteine-rich 
domain and the first half of the carboxy-terminal domain 
Rcccivcd 29 June 1991 
Dyrtrophin. at protein product of the Duchconc muscular dystrophy gcnc. is thoughht to ttrrociatc with the muscle mcmbranc by wty ofu glycoprotein 
complex wbkh wt~s to.puriticd with dyurophin. Hcrc. w tks~ly dcmonstrntc direct biochcmiul cvidcncc for mociation of the curboxy-terminal 
region of dprtrophin with the glycoprotcin complcn. The binding site is found to lie further inwrd than prcvioudy cxpcctcd and conflncd to the 
cyrtcinc-rich dumilin und the hnrt hulf of the rwboxy-tcrminul domain. Since this portiun corresponds well to the region tltwt, when mining. rcwlts 
in scvcrc phcnotyps, our fmding may provide II molcculttr basis of the dieta 
Dyrtrophin; Lreolcmma: Qycoprotcin.binding site; Calpain: Pcptidc mapping 
1 a INTRODUCTION 
Dystrophin, a protein product of the Duchcnnc mus- 
cular dystrophy (DMD) gene, is a spcctrin-like protein 
with ti molecular wcighr of 427 kDu [l-3]. Many immu- 
nohistochcmical studies have established its membrane 
localization in skeletal and cardiac muscles. and its nb- 
scnec in muscles from DMD patients [4-61. A linkage 
between dystrophin and rhc cell mcmbranc is assumed 
to bc mediated by a glycoprotcin complex since. in dc- 
ccrgcnt cxtrticts of strrcolcmma. dystrophin is found in 
a large complex with several orhcr proteins containing 
wheat germ agglutinin (WGA).binding glycoprotcins 
[7-91, 
On the busis of the deduce8 amino acid scqucnw. 
dystrophin is predicted to col..prisc four distinct do- 
muins: an amino.tcrminal domain. a central rod do- 
main, a cystcinc-rich domain and a carboxy=tcrmintll 
domain [3]. Brcuusc the sequence of the last domain is 
highly conscrvcd and shows no apparent rcscmblancc 
to any previously reported protein except dystrophin- 
related protein (DRP) [IO]. and bccauat dclctions of this 
domain often result in loss of dystrophin from the nicm- 
branc [I 1,12]. this carboxy-terminal domain has been 
speculated to bc the mcmbranc-anchoring domain 
[3,13], After the finding that the tightly associcltcd com- 
Rbbrcsiutinttx: DAPC, dyrtrophin and its aaaociutcd protein complex; 
WGA. wheat germ agglutinin. 
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plcx of the sorcolcmmal glycoprorcins co=purificd with 
dystrophin, this speculation has been naturally cx- 
pandcd to ths idea thnt the glycoprotcin-binding site 
exists in this domain [14], Mowcvcr. there bus been no 
direct biochcmicul evidence for association bctwccn this 
domuin and the glycoprotcin complex. and rhus the 
precise glycoprotcin-binding site remains speculative. 
In this paper. by unulyzing calpain fragments of 
dystrophin which still associate wirh rhc glycoprotcins. 
WC firstly dctcrminc on essential region for rhc binding. 
The binding site is confined to the cystcinc-rich domain 
and the first half of the carboxy-tcrminul domain, and 
the last half of the carboxy-terminal domain is found 
not to bc essential for the binding. 
2, EXPERIMENTAL 
2. I. Att$rcrriutt a/ DA PC 
Dyrtrophin and its ttssociutcd prolcin complex (DAPC) was puri- 
lied from rabbit rkclcrul mu&s us previously described [a] cxccpt Ihat 
2 mM of dithiothrcitol (DTr) was added &ring mcmbraii prcpart. 
tian, und 0,s mM during the following chrom~tcgnphic procedure. 
S~~nrplrr wcrc cnnftrmcd not to contain a dctcctablc amount ofdyrtra. 
phin.rchtcd protciil (DRF) [IO] through USC of the DRP-specific pol- 
yclonul antibody [IS] (Ma not shown). 
All antibodies cxccpt Dy4/6D3 ilrc polyclonul und ruiscd uydinrt 
synthetic polypcptidcs corresponding IO the amino aid rcqucnccs of 
humitn dystrophin [3], The positions of umino acid rc&iucs against 
which each nntibody wus ruircd arc UY follows (see Fig, 4h): POOa, 
rcsiducs I l-60; P04d. 440-489; Dy4/GD3, 1, I W-I ,388; P?3u, ?.360- 
2,409; P30b. 3,0953.097; P3l b, 3. IBli-3.200; P33c. 3,373-3,39 I; P34c, 
3,49S-3,544. The mcthodr of prcpnrution and the spcciftcity of the 
antibodicr. cxccpt P30b, P3l b und P33c, wcrc rcportcd previously 
[&IO, 171, The IICW polyclonul untibodics, P30b. P3l b uud P33c, wcrc 
gcncrtttcd in Jiiptlncsc white rabbittr using BSA-conjugutcd tiynthctic 
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Fig. I. Calpain diScstion of RAPC und separation of the rcsultrmt fragments using WCjA-aflinity chrometography. Shown ore a Coomasric 
bluc-stoincd gel (a) and (L biotinyl-WCiA-stained blot I&). Arrows indicate molcsulirr weights of rhc main dystrophin fmgmc& pro&ted by calpain 
digestion. A&AS ond 156.kDu rcprcvcnt dystrophin-nssc&ttcd proteins. Positions of molscul;lr wright rtmdardr ucc indicated by arrowheads on 
the Icft or right of crch panel: from top to bottom, 200. 116.66.42 und 30 kDo, fhc low~it band In lane 3 of(a) is contuminatcd WGA subunits, 
polypcptider. All ant&n! were pursed through a BSA-Scpharorr col. 
umn to remove untibodicr ugainrrt cpitopcs on BSA. Monoclonul anti. 
body Dy4/6D3 [I%] war a gift from Professor L.V,B, Nicholson. 
Digestion was performed tit 25’C for 30 min in buffer C (20 mM 
HEPES, 270 mM NaCl. 2 mM CnCI:, 0.5 mM DTT, 0.1% digitonin, 
pH 7.5) using nr-urlpuin (Sigma) ut u ratio of 100 DAPU calpain 
{w/w). The reaction wus rroppd by rrdding 5 mM EGTA, und then 
the solution was loudcd on WGA-Scphurosc cquilibratcd with bind- 
ing buffer (20 mM HEPES, 0.5 mM NaCI. 3 mM M&I:. 2 mM 
EGTA, 0.5 mM DlT, 10 PgIml Icuprplin, pH 7.5). After collection 
of the unbound fraction and cxtcnrivc washing of the gel with binding 
buffer. bound frugmcr~ts wcrc clutcd with N-acctyl.u.gluco~nn1inc 
(NAGleonIeining buffer (20 mM HEPES. 0.3 M NAG. 0.5 mM 
DTT, O,l% digitonin, IO PgIrnl Icupcptin, pH 7.5). KI trcutmcnl *,is 
performed 11s previously described (81 irnmcdiutcly uftcr the ccueutinn 
of calpnin digestion. 
SDS-PAGE wns prformcd on &IS% grudicnt gels us &scribed by 
Lacmmli 119). For non-dcnuturing PAGE, Davis’ buccr system [W]. 
containing 0.1% digitonin, was used, Twa-dimcnrionul PAGE wus 
pcrformcd. using non-denaturing gets instead of isoclcctric-focusd 
gels, by the method of O’Farrcll [21]. The second dimension H’U ii 
4-l 5% SDS gel described above. Protcinr qaratcd in SDS or non- 
denaturing polyucryiamidc gels wcrc cithcr btuincd with Coomunsic 
blue or trunsfcrrcd clsctrophorctically onto polyvinylidcnc difluoridc 
mcmbruncr [22]. The mcmbruncr wcrc process& for Wcstcrn blotting 
with antibodies to dystrophin or biotinyl-WGA as dezcribcd prcvi- 
aurly [a]. 
2.5. FrprirlF rcquwrri~rg 
Dynrophin frdgmcntr in the WGA-bound or unbound fraction (I25 
pg) were rcpnrutcd on 4-l 5% gmdicnt SDS gel ascording to Moos tr,. 
ct ul. (231 and trrlnsfcrrcd clcctrophorctic~llyonto~ PVDF mrmbnnr. 
The carrcqonding region of the mcmbranr IO cllch ftxgmcnt was used 
us r;implcr for nnalysir. For sequencing. the gas phase rcqucnator 
477A. with on-line phcnylthiohydtintoin amino ucid analyzer, 120A 
(Applied Uioxyncmr). was used. 
3. RESULTS AND DISCUSSION 
As rcportcd previously, dystrophin can be enriched 
from dctcrgent extracts of the sursolcmma by using 
WGA-affinity chromatography, because it forms a 
large protein complex containing WGA-binding 
glycoproteins [7-93. Coomassic blue-stnincd gels of the 
purified dystrophin and its associated protein complex 
(DAPC) shows six proteins other than dystrophin, AO- 
AS. whose molecular w4ghts are 94.62, 52,43. 36 and 
24 kDa, rcspcctivcly [8] (Fig. la, lane 1). The 156.kDo 
glycoprotcin [9] is diffiicu!t o dctcct with protein stnin- 
155 
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Fig. 2. rmmunoblot analysis rhowin the or&in of WCA-bindinp fragments (a and b) and the cfkcf of KI lrcalmcnr on WGA binding of thcsc 
fragments (4. Lanes 8, WGA-bound fraaion; lanes U, WGA-unbound fraction; lanes C, DAPC (control for the specificity ofdyatraphin detection 
of newly prepared untibodicr). Antibodies used for each net al’rtripr urc indicated tit the top of lnncs (Dy46Dj is tibbrcviatcd OS Dy). WGA in 
(c) mcnns biotinyl-WGA staining. The positions of the main fnlgmcnts of dyarophin und the three glycoprolcinr arc indic;ltcd. The molecular weight 
standards (orrowhcads) iire the same us those used in Fig. 1, 
ing, bur can bc dctcctcd with biotinyl-WGA staining 
(see Fig. lb). When this purified DAPC was digested 
with crtlpain, dysrrophin was rapidly attacked and fi- 
n&y degraded to mainly 145, 117, 100, 55, 48 and 31 
kDn fragments, while major dystrophin-associated pro- 
teins, except ACJ and A3a, appcsrcd to be much less 
sensitive to calpain digestion (Fig. la, lane 2). The rcsis- 
tance of the three WGA-binding glycoproteins, the 1% 
kDn protein, A2 and A3b, was confirmed by blotting 
analysis using biotinyl-WGA: the molcsulur weights of 
these proteins changed little after the treatment, and 
they still bound strongly to WGA (Fig. lb), These re- 
sults raised rhc possibility that some dystrophin frag= 
ments retain the ability to bind to WGA through 
glycoprotcins. WC fractionated the calpain-digcstcd 
DAPC by WGA-affinity chromotogrtlphy, and ann- 
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Fig. 3. Tw+dimcnsional polyacrylamidc gel clcctrophoresis of WGAabound fraction, (a) The Ant dimcnaion of 3.54% noa-dcnaturiog PAGE. 
(b,c and d) The rscond dimcnoion of 415% SDS.PAGE. Shown are Coomask bluc-staincd gclr (lane 1 in a and b) and blots or idcntisal gels 
stained with bioCnyl.WGA (lane 2 in a and c) or P33c Cd). Large arrowheads in (a) indicate positions of three lafgc proIcin M&MU ObscrMd 
in the firrt-dimcnsional gel, and those in b-d are corrcspending positions of these complcxn on the scconddimcnsional gels. In kl, sUining 
pnltcrnr of ramplcs not subjcctcd to the first clcctrophorcris are al#, shown on the Icfi edgs of the gclr. The molecular weight standards (small 
arrowhcndr) arc the sumc as those used in Fig, 1, 
lyzcd the bound and unbound fractions on SDS-PAGE 
(luncs 3 and 4 in Fig. la). Besides low-moleculnr=wcight 
proteins, which should bc A2, A3b, A4 and A5, one of 
the main fragncnts of dystrophin, the IOO-kDa frag- 
ment, totally bound to WGA, whereas four of the other 
main fragments, 119, 55, 48 and 31 kDa, were found 
exclusively in the WGA-unbound fraction. The 145- 
kDa fragment was separated into two fractions: WGA- 
binding and -non-binding frngrnents. The former, i45b. 
remained on the resin even after cxtcnsive washing. Bc- 
cause dystrophin itself is not a WGA-binding glysopro- 
tcin, the above results show that 14§b and MO-kDe 
fragmrnts contain the glysoprotcin-binding site. 
To confine the glysoprotcin-binding site on the 
dystrophin molecule, the WGA-bound and -unbound 
fractions were analyzed by immunoblottinp using scv- 
cral anti-dystrophin antibodies which recognize diffcr- 
cnt cpitopcs pread over the cntirc dystrophin molc~culc 
(Figs. 2a and 4b). Polyclonal antibodies, PO&I and 
PO4d, and monoslonal antibody, Dy4/6D3, raised 
against amino acid rcsiducs in the amino=tcrminal half 
of human dystrophin, did not spcsificaily recognize any 
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Fig. 4. Pcptidc mapping of WGA-binding frngmcntr. (a) The rcrults of pcptidc scqucncing of l45b and 1 Il&Da fragmcntr. Initial yields wcrc ?S 
end 34 pmol, lrnsl avcragc rcpctitivc yirldr. 90 and 89%, rapcctivcly. (4) Schcmntic diagram showing lacationr of some dystrophin fragments on 
tht molssulc. The lnqcst bar cprcscr~rr Uac dystrophin molw~lc showing t&domain oqanizition prcdlstcd by Koenig CI al, [3]: from left to right. 
the Id-Cenninal domain (opn box), the central rod domain (li&tly hatched bon). the qruinc-rich domain (black box). nnd the carboxy-terminal 
domain (dotted bon). Den&y hat&cd boxes represent fivcpotcntial non-rcput segments which wcrc prcdictcd to bc targets for protcinesedigcrtion 
~BCXIUSC ul’thcir tlcxiblc strllclurcs [30]. The corresponding portions ofthc pptidcs used to gcncntc the antibodicr in this study PCC indiattcd by 
block blocks above the dyrrtrophin diugmm. nnd rhc highly con=rvcd rcglan of the dystwphin squcncc [14j ir indialtcd below the diagmm by 
u bi-directional L~FOW. A jug&xl lint UI the wrboxy-tctminus indicatcp the muin tlltcrntitivc splicing rite of dyrtrophin [31]. Lusations of some 
dystrophin fmgmcn;? produced by cnlpuin discrtion nrc shown by smaller bars below the di:lgmm on the b;lxix of the rcsulfr prcrcntcd hcrc. Cross 
hatchd bars rcprcsmt WGA-binding fragmtntq und opsn onrr. WGA-non-bindinp ~r:rgmratr. The un:ina urid scale is @cn nt the top. 
fragments mullcr thun 250 kDa in the WGA-bound 
fraction (195 and 145 kDa bands faintly observed in 
lane Et for Dy4/6D3 arc presumably non-specific rc- 
mains of WGA-non-binding fragments roincd dus to 
high titer of this antibody). On the other hund, P34, the 
polyclonal antibody against the corboxy-terminal 
amino acid rcsiducs (3,495-3.544). rccognizcd five 
minor fmgmcnts, all of which bind to WGA. The mini- 
mum size (64 kDa) of the WGA-binding fragments rcc- 
ognizcd by P34c implies that the glycoprotcin-binding 
site is confined to carboxy-terminal -750 amino acids. 
However. P34c dctcctcd ncithcr 145b nor the 100.kDn 
fragment. The former was rcwgnizcd cxclusivcly by 
P23a, whose cpitopc resides in the carboxy-terminal 
half of the central rod domain (2,360-2,409), while the 
latter did not show strong affinity to any of the antibod- 
ies. Interestingly. P23a also recognized the 117-kDa 
fragment, one of the major WGA-non-binding frag- 
ments. Therefore. WC consider the glycoprotcin-binding 
site to precede the cpitopc of P34c and reside within ;1 
portion of 14Sb which does not overlap with the 117- 
kDo fragment. By microsequence analysis, we found 
that these two fragments hare the same amino-terminal 
scqucncc, which shows an identical match to the pub- 
lished amino acid sequence of human dystrophin [3] 
from residue 1,993 (Fig. ta). Thus WC estimated that the 
glycoprorcin-binding sit is present around the cystcinc- 
rich domain (3,ll S-3,269) [3]. This also explained why 
the 100-kDa fragment did tlot rcast with any antibodies. 
To confirm this, we prepared polyclontil antibodies, 
1% 
P30b. P31 b and P33c. which were dircctcd against 
amino ucid residues 3.08%3,097, 3,1863,200 and 
3.373-3.391 of human dystrophin, respectively (see Fig. 
4b). fmmunoblot analysis of the calpain fragments 
using thrsc antibodies rcvctllcd that all of them reacted 
with both l45b and the lOO=kDa fragment (Fig. 2b). On 
the other hand, no WGA.non-binding fragments, in- 
cluding the 117.kDu fragment, were steined. Furthcr- 
more. these rmtihodics detected two additional WGA- 
binding fragments. 35 and 38 kDa, which wcrc not dis- 
cerned from A4 by Coomossic blue staining in Fig. 1. 
These fragments hould correspond to the non-overlap 
region bctwccn l45b rind the 1 I7-kDa fragment. The 
35kDa fragment should bc the smallest WGA-binding 
fragment produced by calpain digestion, and its nmino- 
and carboxy-tcrmini may bc around the cpicopts of 
P30b and P33c. respectively, because the antibodies 
had very low affinity to this fragment. 
To exclude the possibility that the dctcctcd fragments 
remained on the resin due to non-specific binding, we 
carried out the following experiments and confirmed 
direct association between the fragments and the 
glycoprotcins. (i) The association ofdystrophin with the 
glycoprotcin complex is sensitive to tnolar conccntra- 
tions of potassium iodide [7-g]. All fragments also lost 
their WGA-binding activity after KI trcatmcnt, whereas 
the glycoprotcins till rcnxtincd on the resin (Fig. 2c), 
(ii) The WGA-binding fraction of the digest was further 
analyrcd by non-denaturing polyacrylamidc gel clcctro- 
phorcsis followed by SDS-PAGE in a second dimcn- 
Volunrc 308, number ?. FEDS 1ETTERS August 1992 
sion, The first clccrrophorcsis rcvcnlcd three major 
bands (arrowheads in Fig. 30). cash corresponding to 
a lurgc protein oomplcx with one of the WGA-binding 
fragments of dystrophin and P set of glycoprotcins (Fig. 
3b,c,d). (The complex containing the X&Da fragment 
and that containing the 38-kD;r fragment wcrc not ncp 
mated under this resolution.) 
Fig. 4b summarizes the results prcscntcd hcrc. WC 
identified the 359 und 38.kDsr fragments of dystrophin 
which should contain the csscntinl region for glycopro- 
tcin binding. Based on the immunoblot analysis using 
several antibodies (P3Ob. P31b. P33c and P34s) raised 
against he amino-acid scqucnccs howing no intramol- 
ecular homology [3]. WC concluded that thcsc fragments 
mainly cover the cystcinc-rich domain and the first bz:ff 
of the carboxy-terminal domain [3]. but not the last half 
of the curboxy-terminal domain. This region corrc- 
spends well to the highly conscrvcd scqucncc (3.123- 
3.418) between chicken nncl human (>996) [24]. The 
carboxy-tcrminul scqucncc of dystrophin-rclatcd pro- 
tein (DRP), an autosomtll gcnc product with high ho- 
mology to dystrophin observed on the skeletal muscle 
mcmbrunc [lO.lS]. exhibits 82% amino acid identity 
with a large part of (3.187-3.400) this portion. suggcst- 
ing that DRP may also utilize this mcmbranc glycopro- 
tcin complrx, One might imagine a role for Ca ions in 
glycoprotcin binding of dystrophin since the cystcinc- 
rich domain czntains two potential EF-hand-like se- 
qucnccs [3]. However. it should be noted that. in our 
experiments. the chelation of ctr” with EGTA did not 
dissociate the dystrophin fragments from the glycopro- 
tcins (see section 2). 
In this report, WC firstly dcmonstratcd irect associa- 
tion bctvxcn the glycoprotcin complex and the carboxy- 
tcrrninal region of dystrophin, and thus cstublishcd 
mcmbranc anchoring of this region. WC also found that 
the csscntiirl region for binding lay further inward than 
previously cxpcctcd [ 13,141. Our conclusion is bused on 
the analysis of the calpain-digcstcd fragments of dys- 
trophin. Thercforc, we cnnnof complctcly rule out the 
possibility chat calpain digestion disrupted other intcr- 
actions between the glycoprotcins and dystorphin, cspc- 
cially in the last half of the carboxy-terminal domain 
which is highly sensitive to protcolysis (see Fig. 2a). 
Actually. by using the immunogold labeling technique, 
Cullcn et al. showed that the last 17 amino acids of the 
dystrophin cat-boxy-terminus arc found in a narrow 
band enclosing the plasma membrane [25]. Mowcvcr, WC 
believe that the region WC confined is essential, bewusc 
the complete WGA-binding activity of the 35 and 38- 
kDe fragments, and their dissociation after KI trcnt- 
mcnt, explain the main feilturcs of the glycoprotcin 
binding of intnst dystrophin [8,9]. High ssqucncs ron- 
scrvation of this region also supports this idea. 
Recently, some patients wcrc found to produce trun- 
cated dystrophin lacking the carboxy-terminal region 
but show almost normal localization of the protein at 
the surcolcmmn [26-281. Surprisingly. in the most cx- 
trcmc wsc, one of the patients had P deletion which 
removed the carboxy-tcninnl half of the protein [28]. 
fn light of our findings, the defined corboxy-terminal 
region is not the sole mcmbrenc-attaching site, and is 
not necessarily indispensable for the mcmbranc Ioealiz- 
ation, However. more importantly, in spite of the ap 
parent normal msmbranc localization of the truncated 
dystrophin. their phenotypes were scvcrc (ons cast [27] 
is too youn& to make 3 final diagnosis). This is still very 
consistent with the results of Koenig ct 31. [I 11 that the 
region which, when missing, Icads to severe phenotypes 
is limited to the cystcinc-rich domain and the first half 
af the carboxy-terminal domain. This is the region dc- 
fined hcrc to bc essential for the glycoprotcin binding. 
Rcccntly. Ervarti and Campbell [I41 and Ibraghimov- 
Bcskrovnaya et al. [29] showed that the 156.kDa protein 
is an cxtraccllular protein which binds to laminin. 
Hcncc, together with those results, our finding strongly 
supports the idea that the essential cause of the disease 
is the luck of interaction bctwccn this dystrophin car- 
boxy-terminal region and the cxtraccllultrr matrhc, by 
way of the glycoprotcin complex. 
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